TRACON Pharmaceuticals Inc (NAS:TCON)
$ 1.26 0.02 (1.63%) Market Cap: 3.38 Mil Enterprise Value: -4.95 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

TRACON Pharmaceuticals Inc Call to Discuss Collaborative Partnership Agreement with 3D Medicines (Beijing) Co Ltd and Jiangsu Alphamab Biopharmaceuticals Co Ltd Transcript

Dec 20, 2019 / 01:30PM GMT
Release Date Price: $48.8 (-2.01%)
Operator

Greetings. Welcome to the TRACON Pharmaceuticals Conference Call. (Operator Instructions) Please note, this conference is being recorded.

At this time, I'll turn the conference over to Scott Brown, Vice President of Finance. Scott, you may begin.

Scott B. Brown;Charles
TRACON Pharmaceuticals, Inc. - CAO & Head of Finance

Good morning, and thank you for joining us today. As a reminder, we will be making certain forward-looking statements, including statements regarding future development plans and strategy and potential benefits of our product candidates. These statements are subject to various risks that are described in our filings made with the Securities and Exchange Commission, including our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. You are cautioned not to place undue reliance on these forward-looking statements, and we disclaim any obligation to update such statements.

With that, I will now turn the call over to Dr. Charles Theuer, President and CEO of TRACON. Dr. Theuer?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot